Newsfeeds Archive - Page 2 of 4

3 minute read

IMUNON Announces First Patient Enrolled In Phase 1/2 Clinical Trial Of IMNN-001 In Combination With bevacizumab In Advanced Ovarian Cancer

October 18, 8:32 AM

The MRD trial will evaluate the effect of this treatment combination on minimal residual disease.LAWRENCEVILLE, N.J., Oct. 18, 2023 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ:IMNN), a clinical-stage drug-development

IMNN

24 minute read

Options

Stocks That Hit 52-Week Lows On Thursday

By Benzinga Insights

September 28, 2:32 PM

During Thursday's session, 406 companies made new 52-week lows.

AAP

1 minute read

Imunon Highlights Early Data From Lead Program In Ovarian Cancer

By Vandana Singh

September 28, 1:24 PM

Imunon Inc (NASDAQ: IMNN) announces interim progression-free survival (PFS) and overall survival (OS) data with IMNN-001 in its Phase 1/2 OVATION 2 Study of intraperitoneal IMNN-001 in combination with neoadjuvant chemotherapy (NACT) for newly diagnosed with advanced epithelial ovarian, fallopian tube

IMNN

1 minute read

Movers

12 Health Care Stocks Moving In Thursday’s Pre-Market Session

By Benzinga Insights

September 28, 9:05 AM

Gainers Bionomics (NASDAQ:BNOX) shares increased by 579.2% to $6.69 during Thursday’s pre-market session. The company’s market cap stands…

AVTX

25 minute read

Options

Stocks That Hit 52-Week Lows On Tuesday

By Benzinga Insights

September 26, 12:04 PM

On Tuesday, 386 stocks made new 52-week lows.

$TKO

16 minute read

Earnings

Earnings Scheduled For August 10, 2023

By Benzinga Insights

August 10, 6:59 AM

Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report quarterly loss at $0.39 per share on revenue of $1.60 million.

AACG

1 minute read

Earnings

Earnings Outlook For Imunon

By Benzinga Insights

August 9, 12:02 PM

Imunon (NASDAQ:IMNN) is set to give its latest quarterly earnings report on Thursday, 2023-08-10. Here’s what investors need…

IMNN

16 minute read

Earnings

Earnings Scheduled For May 11, 2023

By Benzinga Insights

May 11, 9:58 AM

Companies Reporting Before The Bell • Takeda Pharmaceutical (NYSE:TAK) is likely to report earnings for its fourth quarter. • Exela Technologies (NASDAQ:XELA) is expected to report earnings for its first quarter.

AACG

1 minute read